Travere Therapeutics (TVTX) Cash & Equivalents Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | 26.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.60% |
| Dec 31, 2025 | 58.94% |
| Sep 30, 2025 | 204.68% |
| Jun 30, 2025 | 132.74% |
| Mar 31, 2025 | 43.11% |
| Dec 31, 2024 | 0.62% |
| Sep 30, 2024 | -74.76% |
| Jun 30, 2024 | -54.44% |
| Mar 31, 2024 | -73.20% |
| Dec 31, 2023 | -5.69% |
| Sep 30, 2023 | -4.69% |
| Jun 30, 2023 | -60.57% |
| Mar 31, 2023 | -37.10% |
| Dec 31, 2022 | -62.78% |
| Sep 30, 2022 | 0.67% |
| Jun 30, 2022 | 115.83% |
| Mar 31, 2022 | 73.09% |
| Dec 31, 2021 | 95.53% |
| Sep 30, 2021 | -25.02% |
| Jun 30, 2021 | -64.88% |
| Mar 31, 2021 | 121.18% |
| Dec 31, 2020 | 35.77% |
| Sep 30, 2020 | 207.54% |
| Jun 30, 2020 | 213.48% |
| Mar 31, 2020 | -4.04% |
| Dec 31, 2019 | -39.31% |
| Sep 30, 2019 | -57.89% |
| Jun 30, 2019 | -15.28% |
| Mar 31, 2019 | 14.27% |
| Dec 31, 2018 | 3.50% |
| Sep 30, 2018 | 56.40% |
| Jun 30, 2018 | 0.04% |
| Mar 31, 2018 | 45.97% |
| Dec 31, 2017 | 142.41% |
| Sep 30, 2017 | 314.27% |
| Jun 30, 2017 | 321.96% |
| Mar 31, 2017 | 79.99% |
| Dec 31, 2016 | 8.46% |
| Sep 30, 2016 | -83.00% |
| Jun 30, 2016 | -83.44% |
| Mar 31, 2016 | -80.64% |
| Dec 31, 2015 | 107.67% |
| Sep 30, 2015 | 443.64% |
| Jun 30, 2015 | 220.33% |
| Mar 31, 2015 | 3,151.96% |
| Dec 31, 2014 | 203.55% |
| Sep 30, 2014 | 92.86% |